Projects

IMPACT-Indian Multicenter Pediatric & Adolescent Chronic Kidney Disease Tracking Registry: A Single-Centre Pilot Formative Research Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2031

Project Lead

Dr Priya Pais

Authors

Dr Priya Pais, Dr Arpana Iyengar, Dr Anil Vasudevan, Dr Nivedita Kamath, Dr Soumya Reddy, Dr Denis Xavier, Dr Ryan Fernandez

Project Status

ongoing